Some cancer types also express CD1d, including prostate, glioma, hepatocellular carcinoma, B-CLL, and multiple myeloma, suggesting NKT cells can directly interact with tumors [35-38]. The gene discussed is CD1D; the disease is plasma cell myeloma.